Bausch Health Companies | VRX - Fremdkapital

Aktienkurs
7.77
Täglich Wechseln
0.15 1.97%
Monatlich
10.68%
Jährlich
2.24%
Q2 Prognose
7.53




Fremdkapital Veränderung Datum
Amgen USD 50B 2.43B 2025-12
ANI Pharmaceuticals USD 291.84M 5.84M 2025-12
Aurora Cannabis CAD 33.2M 1.79M 2025-12
Bausch Health Companies USD 20.62B 152M 2025-12
Biogen USD 6.29B 1.4M 2025-09
Bristol-Myers Squibb USD 42.85B 1.62B 2025-12
Canopy Growth CAD 224.99M 1.34M 2025-12
Danaher USD 17.56B 855M 2026-03
Drreddys Laboratories INR 129.19M 1.84M 2025-12
Eli Lilly USD 40.87B 5.6M 2025-12
Gilead Sciences USD 22.13B 6M 2025-12
Nektar Therapeutics USD 63.16M 44.35M 2025-12
Novo Nordisk DKK 118.94B 29.76B 2025-12
Pacira USD 372.19M 4.53M 2025-12
Perrigo USD 3.6B 4.5M 2025-12
Phibro Animal Health USD 603.6M 5.92M 2025-12
Prestige Brands USD 1.05B 39.73M 2025-12
Supernus Pharmaceuticals USD 400.38M 21.13M 2022-03
Vertex Pharmaceuticals USD 111.4M 1.4M 2025-03
Zoetis USD 9.04B 1.97B 2025-12